Targeting MDM2-p53 Interaction for Cancer Therapy: Are We There Yet?Subhasree Nag(Texas Tech University), Ruifeng ZhangCurrent Medicinal ChemistryJanuary 14, 201410.2174/09298673113206660325Cited by 144SaveCiteExport RISWatch citationsRelated PapersThe MDM2-p53 pathway revisited|Journal of Biomedical Research|2013|410